/YTEN

YTEN Stock - Yield10 Bioscience, Inc.

Q: What is the analyst price target for YTEN?

Analyst price target information is not currently available for YTEN.

Q: What is YTEN's market cap?

Market capitalization information is not currently available for YTEN.

Basic Materials|Agricultural Inputs|NASDAQ

$0.34-51.78%

$0.36 (-51.78%) • Dec 20

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+25161.9%upside

Target: $84.64

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for YTEN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.43

52W High$17.26

52W Low$0.24

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$60,000	$450,000	$614,000	$799,000	$806,000
Gross Profit	$-230,000	$-206,000	$36,000	$-4,421,000	$-4,042,000
Gross Margin	-383.3%	-45.8%	5.9%	-553.3%	-501.5%
Operating Income	$-14,417,000	$-13,451,000	$-11,692,000	$-9,609,000	$-8,596,000
Net Income	$-14,455,000	$-13,566,000	$-11,031,000	$-10,206,000	$-12,956,000
Net Margin	-24091.7%	-3014.7%	-1796.6%	-1277.3%	-1607.4%
EPS	$-43.66	$-66.25	$-55.95	$-103.21	$-851.98

Company Overview

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

Hold / Neutral

100%

Sell / Underperform

Analyst Consensus🔴 Bearish

0 Bullish1 Neutral/Bearish

Price Targets

No price targets available

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
February 8th 2024	Lake Street	Downgrade	Hold	-

Earnings History & Surprises

YTEN

Beat Rate

18%

Last 17 quarters

Avg Surprise

-430.3%

EPS vs Estimate

Beats / Misses

3/14

Last 12 quarters

Latest EPS

$-5.04

Q3 2024

EPS Surprise History

Q4 22

-1.4%

$-17.03vs$-16.79

Q1 23

-2778.3%

$-16.07vs$0.60

Q2 23

-69.0%

$-18.23vs$-10.79

Q3 23

-33.4%

$-15.35vs$-11.51

Q4 23

-32.3%

$-9.83vs$-7.43

Q1 24

+10.0%

$-0.27vs$-0.30

Q2 24

-145.1%

$-6.47vs$-2.64

Q3 24

-27.3%

$-5.04vs$-3.96

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2025	Aug 12, 2025	—	—	—	—
Q2 2025	May 13, 2025	—	—	—	—
Q4 2024	Nov 18, 2024	$-1.03	—	—	—
Q3 2024	Aug 14, 2024	$-3.96	$-5.04	-27.3%	✗ MISS
Q2 2024	Apr 1, 2024	$-2.64	$-6.47	-145.1%	✗ MISS
Q1 2024	Mar 12, 2024	$-0.30	$-0.27	+10.0%	✓ BEAT
Q4 2023	Nov 14, 2023	$-7.43	$-9.83	-32.3%	✗ MISS
Q3 2023	Aug 14, 2023	$-11.51	$-15.35	-33.4%	✗ MISS
Q2 2023	May 10, 2023	$-10.79	$-18.23	-69.0%	✗ MISS
Q1 2023	Mar 14, 2023	$0.60	$-16.07	-2778.3%	✗ MISS
Q4 2022	Nov 14, 2022	$-16.79	$-17.03	-1.4%	✗ MISS
Q3 2022	Aug 10, 2022	$-16.55	$-16.79	-1.5%	✗ MISS
Q2 2022	May 11, 2022	$-15.83	$-16.31	-3.0%	✗ MISS
Q1 2022	Mar 9, 2022	$-15.35	$-14.63	+4.7%	✓ BEAT
Q4 2021	Nov 10, 2021	$-15.11	$-11.75	+22.2%	✓ BEAT
Q3 2021	Aug 11, 2021	$-12.71	$-15.35	-20.8%	✗ MISS
Q2 2021	May 11, 2021	$-11.03	$-14.39	-30.5%	✗ MISS
Q1 2021	Mar 16, 2021	$-0.70	$-18.94	-2605.7%	✗ MISS
Q4 2020	Nov 12, 2020	$-19.42	$-20.86	-7.4%	✗ MISS
Q3 2020	Aug 11, 2020	$-1.30	$-22.06	-1596.9%	✗ MISS

Frequently Asked Questions about YTEN

What is YTEN's current stock price?

Yield10 Bioscience, Inc. (YTEN) is currently trading at $0.34 per share. The stock has moved -51.78% today.

What is the analyst price target for YTEN?

The average analyst price target for YTEN is $84.64, based on 1 analyst.

What sector is Yield10 Bioscience, Inc. in?

Yield10 Bioscience, Inc. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the NASDAQ exchange.

What is YTEN's market cap?

Yield10 Bioscience, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does YTEN pay dividends?

No, Yield10 Bioscience, Inc. does not currently pay a dividend to shareholders.